Evidence map›Paper›PMID 36686683›Full record

ArticleFrontiers in pharmacology2022

Bibliometric and visualized analysis of sodium-Glucose cotransporter 2 inhibitors.

He Sun, Zhongqing Wang, Yuxi Wang, Haichuan Rong, Danyang Wang, Xiangnian Liu, Ke Jin, Zhicheng Sun, Qiuling Fan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

He SunDepartment of Nephrology, The First Hospital of China Medical University, Shenyang, China.
Zhongqing WangDepartment of Information Center, The First Hospital of China Medical University, Shenyang, China.
Yuxi WangDepartment of Clinical Medicine, China Medical University, Shenyang, China.
Haichuan RongDepartment of Clinical Medicine, China Medical University, Shenyang, China.
Danyang WangDepartment of Clinical Medicine, China Medical University, Shenyang, China.
Xiangnian LiuDepartment of Clinical Medicine, China Medical University, Shenyang, China.
Ke JinDepartment of Clinical Medicine, China Medical University, Shenyang, China.
Zhicheng SunDepartment of Clinical Medicine, China Medical University, Shenyang, China.
Qiuling FanDepartment of Nephrology, The First Hospital of China Medical University, Shenyang, China.
China Medical University · CNShanghai First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bibliometricco-occurrence analysisdiabetic cardiomyopathyheart failuresodium—glucose cotransporter 2 inhibitorvisualization

Identifiers

PMID36686683
PMCPMC9846544
OpenAlexW4313584483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.